Ignite Creation Date:
2025-12-24 @ 2:28 PM
Ignite Modification Date:
2026-01-25 @ 12:32 AM
Study NCT ID:
NCT01712659
Status:
TERMINATED
Last Update Posted:
2023-01-10
First Post:
2012-10-20
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Ruxolitinib for Adult T-Cell Leukemia
Sponsor:
National Cancer Institute (NCI)
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
130006
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None